Since AKT/mTOR appears to play a central role in signaling caused by many growth factors to regulate cell proliferation and survival, some mTOR inhibitors, such as rapamycin and CCI-779, are tested as anti-cancer agents [37,41,42]. Here, AKT1 is linked to cancer.